Kwality Pharmaceuticals Balance Sheet Annual

Trade

BSE: 539997 | NSE: - | ISIN: INE552U01010 | Sector: Biotechnology & Drugs

869.90 +7.20 (0.83%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	5.94	7.36	12.95	5.81
Cashand Short Term Investments	5.94	7.36	12.95	10.25
Accounts Receivable- Trade Net	114.39	71.69	69.13	35.71
Total Receivables Net	114.39	82.04	94.33	78.29
Total Inventory	78.39	86.31	53.36	17.36
Other Current Assets Total	43.97	31.48	67.18	0.00
Total Current Assets	242.69	207.20	227.82	105.90
Property/ Plant/ Equipment Total- Net	139.05	134.79	103.88	59.42
Long Term Investments	0.00	0.00	0.00	0.73
Other Long Term Assets Total	12.47	11.64	8.89	0.04
Total Assets	394.21	353.63	340.59	166.26
Accounts Payable	44.32	35.19	34.51	26.21
Notes Payable/ Short Term Debt	78.56	62.96	33.72	16.45
Other Currentliabilities Total	28.97	27.79	71.25	29.11
Total Current Liabilities	151.85	125.95	139.49	78.29
Long Term Debt	19.56	27.30	20.29	18.26
Total Long Term Debt	19.56	27.30	20.29	18.26
Total Debt	98.12	90.26	54.01	41.23
Deferred Income Tax	0.00	0.41	0.27	-
Minority Interest	-1.63	-1.45	-1.35	-1.30
Other Liabilities Total	0.22	0.90	0.75	9.86
Total Liabilities	170.00	153.12	159.45	105.11
Common Stock Total	10.38	10.38	10.38	10.38
Retained Earnings( Accumulated Deficit)	213.84	190.14	170.77	50.78
Total Equity	224.21	200.52	181.14	61.15
Total Liabilities Shareholders' Equity	394.21	353.63	340.59	166.26
Total Common Shares Outstanding	1.04	1.04	1.04	1.04
Tangible Book Valueper Share Common Eq	216.08	193.25	174.58	58.94
Short Term Investments	-	-	-	4.44
Note Receivable- Long Term	-	-	-	0.17
Current Portof LT Debt/ Capital Leases	-	-	-	6.51